StockNews.AI
SYK
StockNews.AI
21 days

Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases

1. Stryker launched the InThrill Thrombectomy System, targeting AV access thrombectomy. 2. The system improves clot removal efficiency with innovative features. 3. Inari Medical's acquisition enhances Stryker's vascular care capabilities. 4. First successful use reported by UPMC on May 19, 2025. 5. Stryker impacts 150 million patients annually with its medical technologies.

M&A
-0.65%Current Return
VS
-0.51%S&P 500
$403.0107/29 10:07 AM EDTEvent Start
$400.4107/30 04:29 PM EDTLatest Updated
7m saved
Insight
Article

FAQ

Why Bullish?

The launch of a groundbreaking product can boost investor confidence, similar to previous innovative launches by Stryker that historically increased stock prices.

How important is it?

The launch represents a strategic move that reinforces Stryker's market leadership, likely influencing investor sentiment and stock performance positively.

Why Long Term?

New product introductions often translate to sustained revenue growth over time; the thrombectomy market has large potential value.

Related Companies

VARBSXTMH
, /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal. The next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal. The second generation InThrill Thrombectomy System is an 8 French over-the-wire system comprising the InThrill thrombectomy catheter and the InThrill sheath. InThrill is built upon a familiar platform, optimized to become the standard for AV access and small vessel thrombectomy. Offering unmatched efficiency and clot removal, InThrill has distinctive features which include: Increased radial force for improved luminal wall apposition for optimized clot removal Offset single open mouth to optimize clot capture and removal Internal struts for even clot distribution within the element Redesigned backend to streamline ergonomics and improve the user experience. On May 19, 2025, Dr. Joshua Pinter and Dr. Anish Ghodadra of the UPMC health care system performed the first commercial case using the new InThrill Thrombectomy System. "The next generation of InThrill has made our thrombectomies more effective and consistent than ever," said Dr. Pinter. "Inari's dedication to building a small vessel tool has changed our paradigm of treatment for AV access thrombectomy," added Dr. Ghodadra."The launch of the next-generation InThrill Thrombectomy System reflects our deep commitment to solving real-world challenges in vascular care," said Tim Lanier, president, Inari Division. "This latest innovation delivers new tools and enriches our work with physicians in the vascular space."For more information, visit https://www.inarimedical.com/inthrill-thrombectomy-systemAbout StrykerStryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.On February 19, 2025, Stryker acquired Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.Media contact:Sacha RicarteDirector, Communications - Inari[email protected]Drs. Anish Ghodadra and Joshua Pinter are not paid consultants of Inari Medical. All views and opinions expressed here are their own and do not represent those of Inari Medical.Indications for Use:The InThrill Thrombectomy System is indicated for (1) the non-surgical removal of thrombi and emboli from blood vessels, including arteriovenous fistulae and arteriovenous grafts for dialysis access, and synthetic grafts and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel/graft. The InThrill Sheath is indicated for use as a conduit for the insertion of endovascular devices into the peripheral vasculature while minimizing blood loss associated with such insertions. The InThrill Thrombectomy System is intended for use in the peripheral vasculature. The InThrill Thrombectomy System is not intended for use in deep vein thrombosis (DVT) treatment.Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.SOURCE Stryker WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News